Latest Derivatives News

Macquarie Technology Group Limited reported solid FY25 results with continued EBITDA growth and strong cash conversion, underpinned by strategic investments in data centre capacity and AI capabilities.

Global Health Limited reported a reduced net loss for FY2025, driven by growing subscription revenue and strategic AI integration as it transitions to a SaaS platform.

Ark Mines reports its Stage-3 drilling at Sandy Mitchell is ahead of schedule, aiming to nearly quintuple its measured mineral resource and fuel a pivotal Pre-Feasibility Study.

Worley Limited posted robust full-year 2025 results, marked by strong revenue growth, margin expansion, and a significant increase in backlog, underpinned by major contract wins and sustainability progress.

Bio-Gene Technology Limited reported a net loss of AUD 2.58 million for FY2025 while making significant strides in developing its bio-insecticides Flavocide and Qcide, securing US Department of Defense grants and expanding global partnerships.

Tribeca Global Natural Resources Limited announces a fully franked $0.05 final dividend for FY25 alongside amendments to its Dividend Reinvestment Plan designed to protect shareholder value. The company also launches a 10% on-market share buy-back aiming to capitalize on shares trading below net tangible asset backing.

Marimaca Copper Corp. has released a Definitive Feasibility Study for its Marimaca Oxide Deposit in Chile, highlighting a robust 13-year mine life, low capital intensity, and strong financial returns. The study confirms a maiden ore reserve and positions the project as a competitive copper producer with advanced permitting and financing underway.

Imricor Medical Systems reported a sharp 52% revenue decline and a 92% increase in net loss for H1 2025, offset by a $42.8 million equity raise boosting liquidity. The company is investing heavily in European sales and clinical trials while pursuing FDA approval.

Perpetual Resources has reported exceptional preliminary caesium oxide grades up to 30.11% at its Igrejinha prospect, underscoring the strategic potential of this rare mineral amid constrained global supply. Certified assays and maiden drilling results are anticipated soon, promising to clarify the project's economic outlook.

INOVIQ Limited reported a $6.9 million net loss for FY25 while making significant strides in its exosome-based cancer diagnostics and therapeutics pipeline, including a breakthrough ovarian cancer screening test and promising CAR-exosome therapy results.

Rural Funds Group reported a solid FY25 with rising property and farming income driven by macadamia developments, while maintaining stable distributions and preparing for significant capital expenditure in FY26.

BrainChip Holdings reports a significant revenue surge and reduced losses in H1 2025, underpinned by new contracts, strategic collaborations, and an expanded funding agreement.